Cytokinetics sec filings

WebMar 31, 2024 · CYTK Cytokinetics, Incorporated SEC Filings 8.71K followers $35.19 0.98 ( +2.86%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $35.70 +0.51 (+1.45%) 5:56 … WebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop

Cytokinetics, Incorporated (NASDAQ:CYTK) Position Increased by …

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. WebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). how to submit a screenplay to an agent https://office-sigma.com

Cytokinetics, Incorporated (CYTK) - Yahoo Finance

WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … WebNov 4, 2024 · SEC Filings Cytokinetics Inc (CYTK) 10-Q Quarterly Report Fri Nov 04 2024 SEC Filings CYTK Valuations Intrinsic Value Financial Stability Financial Ratios Insider … WebFeb 24, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies reading korfball club

Cytokinetics Inc (CYTK) Proxy Statements Form DEF 14A April 2024

Category:Allspring Global Investments Holdings LLC Has $8.88 Million Stock ...

Tags:Cytokinetics sec filings

Cytokinetics sec filings

Cytokinetics Announces Pricing of $450 Million Convertible

WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ... WebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and …

Cytokinetics sec filings

Did you know?

WebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … WebApr 10, 2024 · Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. WebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ...

WebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … WebFeb 25, 2024 · Cytokinetics Inc (CYTK) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Earnings Press Release 10-K Annual Report 10-K …

WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? …

WebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER … reading ks1 national curriculumWebItem 1.01 Entry into a Material Definitive Agreement. On February 1, 2024, Cytokinetics, Incorporated ("Cytokinetics") entered into a Royalty Purchase Agreement (the "Royalty Agreement") with RPI Finance Trust ("RPI"), an entity related to Royalty Pharma. reading korean with culture pdfWebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th … reading kyoceraWebMar 15, 2024 · Wed., March 15, 2024 MarketBeat Advisory Research Inc. lowered its holdings in Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 32.7% during the third quarter, according to its most recent filing with the … reading kpmg officeWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … reading ks2 mark schemeWebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … reading kotlc fanficWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. ... SEC Filings. Document Details. Form. 144 Filing Date. Apr 13, 2024 ... reading korean with culture 4